Iga Swiatek can now officially lay the doping saga to rest as the World Anti-Doping Agency has confirmed that they won't appeal the ruling made by the International Tennis Integrity Agency.
In late November, the ITIA announced that the Polish tennis star tested positive for trimetazidine and that she accepted a one-month ban.
In their statement, the ITIA also underlined that the world No. 2 was able to prove that a banned substance entered her body through contaminated melatonin pills and that it definitely wasn't intentional.
While Swiatek received only a symbolic one-month suspension, there was still a chance that the WADA would contest that verdict - just as they did in the Jannik Sinner case.
But after reviewing the case, the WADA accepted that the 23-year-old's explanation was valid and also determined that the ITIA did a good job and that everything was conducted properly.
WADA: There would be no scientific grounds to challenge it at CAS
"The World Anti-Doping Agency (WADA) confirms that following a thorough review, it will not lodge an appeal to the Court of Arbitration for Sport (CAS) in the case of Polish tennis player, Iga witek, who tested positive for trimetazidine (TMZ), a prohibited substance, in August 2024," the WADA said in a statement.
"WADA has conducted a full review of the case file related to the ITIA decision, which it received on 29 November. WADAs scientific experts have confirmed that the specific contaminated melatonin scenario, as presented by the athlete and accepted by the ITIA, is plausible and that there would be no scientific grounds to challenge it at CAS.
"Further, WADA sought advice from external legal counsel, who considered that the athletes contamination explanation was well evidenced, that the ITIA decision was compliant with the World Anti-Doping Code, and that there was no reasonable basis to appeal it to the CAS."
Meanwhile, the Pole just defeated Eva Lys 6-0 6-1 to reach the Australian Open quarterfinal.
It has been a great day for the former world No. 1.
